Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1999; 33:250-260
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zile, M. R.
Right arrow Articles by Cooper, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zile, M. R.
Right arrow Articles by Cooper, G., IV

Role of microtubules in the contractile dysfunction of hypertrophied myocardium

Michael R. Zile, MD, FACC*, Masaaki Koide, MD*, Hiroshi Sato, MD*, Yoshiki Ishiguro, MD{ddagger}, Chester H. Conrad, MD, PhD{dagger}, J. Michael Buckley, MS*, James P. Morgan, MD, PhD, FACC{ddagger} and George Cooper, IV, MD*

* Cardiology Section of the Department of Medicine and the Department of Physiology, Gazes Cardiac Research Institute, Medical University of South Carolina, and the Veterans Administration Medical Center, Charleston, South Carolina, USA
{dagger} Veterans Administration Medical Center, Boston, Massachusetts, USA
{ddagger} Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA



View larger version (22K):

[in a new window]
 
Figure 1 Contractions of a normal papillary muscle. Panel A: Shortening extent during an isotonic contraction at baseline. Panel B: Shortening extent during an isotonic contraction after colchicine. Panel C: Active tension during an Lmax isometric contraction at baseline. Panel D: Active tension during an Lmax isometric contraction after colchicine.

 


View larger version (21K):

[in a new window]
 
Figure 2 Contractions of a PAB papillary muscle. Panel A: Shortening extent during an isotonic contraction at baseline. Panel B: Shortening extent during an isotonic contraction after colchicine. Panel C: Active tension during an Lmax isometric contraction at baseline. Panel D: Active tension during an Lmax isometric contraction after colchicine.

 


View larger version (27K):

[in a new window]
 
Figure 3 Relationship between developed force and muscle length in normal papillary muscles before (closed circles) and after (open circles) colchicine and in PAB papillary muscles before (closed triangles) and after (open triangles) colchicine. *p < 0.05 vs. normal baseline.

 


View larger version (23K):

[in a new window]
 
Figure 4 Relationship between shortening extent and force (Panel A) and shortening velocity and force (Panel B) in normal papillary muscles before (closed circles) and after (open circles) colchicine and in PAB papillary muscles before (closed triangles) and after (open triangles) colchicine. *p < 0.5 vs. normal baseline.

 


View larger version (15K):

[in a new window]
 
Figure 5 Time-dependent changes in contractile state in normal (circles) and PAB (triangles) papillary muscles. Upper Panel: Active force. Lower Panel: Shortening velocity.

 


View larger version (17K):

[in a new window]
 
Figure 6 Time-dependent changes in contractile state in a pair of papillary muscles from a PAB cat. Upper Panel: Active force. Lower Panel: Shortening velocity. Papillary muscle 1 (open triangles) was exposed to colchicine after mechanical performance had reached an equilibrium at 120 min. Papillary muscle 2 (closed triangles) was not exposed to colchicine.

 


View larger version (17K):

[in a new window]
 
Figure 7 Time-dependent changes in contractile state in a pair of papillary muscles from a PAB cat. Upper Panel: Active force. Lower Panel: Shortening velocity. Papillary muscle 1 (open triangles) was exposed to colchicine at 210 min, 90 min after it had reached mechanical equilibrium. Papillary muscle 2 (closed triangles) was not exposed to colchicine.

 


View larger version (17K):

[in a new window]
 
Figure 8 Time-dependent changes in contractile state in a normal control papillary muscle (circles) and in a normal papillary muscle treated with taxol (triangles). Upper Panel: Active force. Lower Panel: Shortening velocity.

 


View larger version (30K):

[in a new window]
 
Figure 9 Immunoblots of normal and PAB papillary muscles. Data are presented in pairs, with free (soluble) ß-tubulin in lane 1 and polymerized ß-tubulin in lane 2 for each pair.

 


View larger version (73K):

[in a new window]
 
Figure 10 Immunofluorescence confocal micrographic analysis of microtubules in normal and PAB papillary muscles. Panel A: Normal muscle not exposed to colchicine. Panel B: Normal muscle after colchicine. Panel C: PAB muscle not exposed to colchicine. Panel D: PAB muscle after colchicine. Scale bar = 25 µm.

 


View larger version (26K):

[in a new window]
 
Figure 11 Aequorin studies of RV papillary muscle intracellular calcium transients. Upper Panel: Developed tension. Lower Panel: Aequorin calcium light signal. Data were obtained at baseline (solid line) and after treatment with colchicine (dashed line) in muscles from normal and PAB cats.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement